Open Access

SCD Risk Stratification: Which Patient Benefits from the Wearable Cardioverter Defibrillator?

Congress Session

About the speaker

Doctor Mauro Biffi

S. Orsola-Malpighi Policlinic, Bologna (Italy)
26 presentations
0 follower

5 more presentations in this session



The Power of Per-Protocol Analyses: What Have We Learned from the VEST-Trial?

Speaker: Associate Professor S. Boveda (Toulouse, FR)


Predictors of Sudden Cardiac Death: What Role Does the Heart Rate Play?

Speaker: Professor J. Sperzel (Bad Nauheim, DE)


Heart Failure Patient Management: Improved Outcomes for WCD Patients?

Speaker: Professor D. Bondermann (Vienna, AT)


Discussion and Summary.

Speaker: Professor C. Leclercq (Rennes, FR)


Access the full session

The Wearable Cardioverter Defibrillator (WCD): Clinical Update and Future Directions for the Management of Patients with Ventricular Arrhythmias

Speakers: Doctor M. Biffi, Associate Professor S. Boveda, Professor J. Sperzel, Professor D. Bondermann, Professor C. Leclercq

About the event


ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Related content

Open Access

Pacing in specific conditions.

29 August 2021

Open Access

Challenges in SCD risk stratification.

28 August 2021

Open Access

Wearable devices and their role in sub-clinical arrhythmia detection.

28 August 2021

This platform is supported by

logo Novo Nordisk